AzTrials
AzTrials

Sleep DeprivationNCT06636318

Immune Status After Being on Call for 24 Hrs

An observational study of Sleep Deprivation, run by University of Chicago at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Sleep deprivation is a prevalent problem in modern societies. Sleep deprivation can cause hormonal changes, such as an increase in cortisol, as well as inflammation. Animal studies have shown an increase in inflammatory cytokine production following sleep deprivation. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Sleep Deprivation
What is being tested?
Blood Sample Collection and Actigraph (GT9X-BT) Monitor
Type of treatment
Medical device
How many people
60 participants
Where
1 siteUnited States
Study dates
17 Oct 2024to Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: General Surgery residents, on during 24-hour shifts

Who may be able to join

  • Healthy subjects
  • Surgery residents in a 24-hour shift rotation
  • Gender of subjects: Males and females
  • Age of subjects: 18 years old and older
  • Racial and Ethnic Origin: Any race or ethnicity

Who cannot join

  • Unwilling/unable to sign informed consent
  • Vulnerable Subjects/Subject Capacity to provide consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Angelica Perez-Gutierrez, MD contact

773-834-5087

rperezgutierrez@bsd.uchicago.edu

Leila Yazdanbakhsh contact

leila.yazdanbakhsh@bsd.uchicago.edu

United States1 site, 1 recruiting
  • The University of Chicago

    Chicago, Illinois, 60637

    Shalitha Johnson, 773-834-8758, sjohnson28@bsd.uchicago.edu

    Leila Yazdanbakhsh, 773-834-5087, leila.yazdanbakhsh@bsd.uchicago.edu

    Recruiting

Other trials in United States

About this study

Official title: Impact of a 24-hour Shift Call on the Immune Status of Surgery Residents

Sleep deprivation is a prevalent problem in modern societies. Sleep deprivation can cause hormonal changes, such as an increase in cortisol, as well as inflammation. Animal studies have shown an increase in inflammatory cytokine production following sleep deprivation. Additionally, humans experiencing sleep deprivation may experience a decrease in natural killer cells and lymphocytes.

Physicians, particularly those in surgical specialties, are often subjected to sleep deprivation as part of their medical residency training. This study hypothesizes that after 24-hour shifts, there is an increase in inflammatory response and impairment of the immune response against unspecific activation. This proposal aims to provide insight into the impact of sleep deprivation on the immune system of surgery residents by characterizing the phenotype and function of immune cells, as well as their correlation with biometric data.

Being tested
Blood Sample Collection, Actigraph (GT9X-BT) Monitor
Medical subject headings
Sleep Deprivation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood Sample CollectionDiagnostic test

    To characterize the phenotype and function of immune cells in surgery residents before and after a 24-hour shift, and before and after a month of being "on call". Along with to investigate the relationship between sleep deprivation, physical activity, and different immune responses.

  • Actigraph (GT9X-BT) MonitorDevice

    Participants will be asked to wear their monitor every day for a week. The monitor will collect their step count, sleep and heart rate automatically. Participants will return their monitor at visit 5 (day 30) of the study.

Study groups in NCT06636318
Study groupRoleWhat they receive
General Surgery ResidentsGeneral Surgery residents on during 24-hour rotation shifts
Receives: Diagnostic Test: Blood Sample Collection; Device: Actigraph (GT9X-BT) Monitor

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Characterization of the phenotype and function of immune cells using flow cytometry

    Specifically, T cells, B cells, dendritic cells, macrophages, and natural killer cells will be identified and analyzed. Memory cells, co-inhibitor markers, and regulatory markers will also be evaluated. The function will be analyzed based on the intracellular expression of effector molecules and cytokines after unspecific activation with CD3-CD28 beads.

    Measured: 24 hours

Secondary outcomes (3)
  1. Analyze the biometric data and correlate it with changes in sleep deprivation

    To examine the associations, participants will be using an activity and sleep monitor.

    Measured: One week before rotation and the last week of rotation

  2. Analyze the biometric data and correlate it with changes in the immune response

    To examine the associations, participants will be using an activity and sleep monitor.

    Measured: One week before rotation and the last week of rotation

  3. Analyze the biometric data and correlate it with changes in physical activity

    To examine the associations, participants will be using an activity and sleep monitor.

    Measured: One week before rotation and the last week of rotation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Oct 2024
  2. Study start17 Oct 2024
  3. Primary completionDec 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06636318
Sponsor's protocol ID
IRB24-1426
Status last verified
Dec 2025
First submitted
27 Sep 2024
Last updated
9 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Sleep Deprivation, run by University of Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Angelica Perez-Gutierrez, MD (773-834-5087, rperezgutierrez@bsd.uchicago.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Characterization of the phenotype and function of immune cells using flow cytometry (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in